d'Oleire F - Search Results

1

Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.

Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oleire F, Qu RP, Wilding G, Stewart JA. Robins HI, et al. Among authors: d oleire f. J Clin Oncol. 1997 Jan;15(1):158-64. doi: 10.1200/JCO.1997.15.1.158. J Clin Oncol. 1997. PMID: 8996137 Clinical Trial.

2

Cytokine induction by 41.8 degrees C whole body hyperthermia.

Robins HI, Kutz M, Wiedemann GJ, Katschinski DM, Paul D, Grosen E, Tiggelaar CL, Spriggs D, Gillis W, d'Oleire F. Robins HI, et al. Cancer Lett. 1995 Nov 6;97(2):195-201. doi: 10.1016/0304-3835(95)03976-4. Cancer Lett. 1995. PMID: 7497463

3

Canine bone marrow as a potential thermal sanctuary during the plateau phase of 41.8 degrees C whole body hyperthermia.

Woods JP, Schmitt CL, Rosenthal RC, D'Oleire F, Robins HI. Woods JP, et al. Int J Hyperthermia. 1995 Jan-Feb;11(1):49-57. doi: 10.3109/02656739509004947. Int J Hyperthermia. 1995. PMID: 7714370 Free article.

4

Step down heating and melphalan: cytotoxic interactions and clinical implications.

d'Oleire F, Kutz ME, Bird A, Robins HI. d'Oleire F, et al. Melanoma Res. 1994 Oct;4(5):303-5. doi: 10.1097/00008390-199410000-00006. Melanoma Res. 1994. PMID: 7858414

5

Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia.

Robins HI, d'Oleire F, Kutz M, Bird A, Schmitt-Tiggelaar CL, Cohen JD, Spriggs DR. Robins HI, et al. Cancer Lett. 1995 Feb 10;89(1):55-62. doi: 10.1016/0304-3835(95)90158-2. Cancer Lett. 1995. PMID: 7882302

6

Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.

Robins HI, Cohen JD, Schmitt CL, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, d'Oleire F, Longo W, Heiss C, et al. Robins HI, et al. J Clin Oncol. 1993 Sep;11(9):1787-94. doi: 10.1200/JCO.1993.11.9.1787. J Clin Oncol. 1993. PMID: 8355046 Clinical Trial.

7

Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.

Robins HI, D'Oleire F, Grosen E, Spriggs D. Robins HI, et al. Among authors: d oleire f. Anticancer Res. 1997 Jul-Aug;17(4B):2891-4. Anticancer Res. 1997. PMID: 9329556 Review.

8

A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.

Robins HI, Katschinski DM, Longo W, Grosen E, Wilding G, Gillis W, Kraemer C, Tiggelaar CL, Rushing D, Stewart JA, Spriggs D, Love R, Arzoomanian RZ, Feierabend C, Alberti D, Morgan K, Simon K, d'Oleire F. Robins HI, et al. Among authors: d oleire f. Cancer Chemother Pharmacol. 1999;43(5):409-14. doi: 10.1007/s002800050915. Cancer Chemother Pharmacol. 1999. PMID: 10100597

9

Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy.

Katschinski DM, Wiedemann GJ, Longo W, d'Oleire FR, Spriggs D, Robins HI. Katschinski DM, et al. Among authors: d oleire fr. Cytokine Growth Factor Rev. 1999 Jun;10(2):93-7. doi: 10.1016/s1359-6101(99)00006-4. Cytokine Growth Factor Rev. 1999. PMID: 10743501 Review.

10

Hematological effects of radiant heat-induced whole body hyperthermia on dogs.

Woods JP, Schmitt-Tiggelaar CL, d'Oleire F, Rosenthal RC, Robins HI. Woods JP, et al. Among authors: d oleire f. Can J Vet Res. 1996 Jan;60(1):75-8. Can J Vet Res. 1996. PMID: 8826000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page